Cargando…

Transcriptional profiling of leukocytes from rheumatoid arthritis patients before and after anti-tumor necrosis factor therapy: A comparison of anti-nuclear antibody positive and negative subsets

Anti-nuclear antibodies (ANAs) may be induced in patients with rheumatoid arthritis (RA) receiving anti-tumor necrosis factor (TNF) therapy with TNF inhibitors (TNFi), etanercept, infliximab or adalimumab. In the present study, 11 patients who were TNFi drug naive were started on TNFi at a time of h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Laurie S., Reimold, Andreas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443193/ https://www.ncbi.nlm.nih.gov/pubmed/28565826 http://dx.doi.org/10.3892/etm.2017.4265

Ejemplares similares

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
por: Kuramoto, Nobuo, et al.
Publicado: (2017)

Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
por: Cavazzana, I, et al.
Publicado: (2005)

Rheumatoid Arthritis and Anti-Thyroid Antibodies
por: Yavasoglu, Irfan, et al.
Publicado: (2009)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
por: Julià, Antonio, et al.
Publicado: (2021)

Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
por: Alivernini, Stefano, et al.
Publicado: (2019)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis
por: Ohmura, Koichiro, et al.
Publicado: (2010)

Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients
por: Viatte, Sebastien, et al.
Publicado: (2012)

Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles
por: van Beers, Joyce JBC, et al.
Publicado: (2012)

Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis
por: Tymms, Kathleen, et al.
Publicado: (2021)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
por: Trier, Nicole H., et al.
Publicado: (2019)

Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis
por: Mori, Ayano, et al.
Publicado: (2020)

The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients
por: Kolarz, Bogdan, et al.
Publicado: (2021)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti–Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis
por: Okamoto, Yuko, et al.
Publicado: (2021)

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 ‘shared epitope’ alleles
por: Wagner, Catriona A, et al.
Publicado: (2015)

Is Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti–Citrullinated Protein Antibody–Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward
por: Boer, Aleid C., et al.
Publicado: (2018)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor
por: Othman, Maizatul A., et al.
Publicado: (2017)

The association of anti-CCP antibodies with disease activity in rheumatoid arthritis
por: Serdaroğlu, Münevver, et al.
Publicado: (2008)

Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis
por: El-Gabalawy, Hani S, et al.
Publicado: (2004)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
por: Yu, Hui-Chun, et al.
Publicado: (2019)

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
por: Lv, Dawei, et al.
Publicado: (2022)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
por: Wu, Chao-Yi, et al.
Publicado: (2021)

Rethink About the Role of Rheumatoid Factor and Anti-citrullinated Protein Antibody in Rheumatoid Arthritis
por: Sung, Wang Yu, et al.
Publicado: (2021)

The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis
por: Villanueva-Romero, Raúl, et al.
Publicado: (2018)

Dendritic cell subsets in rheumatoid arthritis
por: Summers, K, et al.
Publicado: (2001)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
por: Davignon, Jean-Luc, et al.
Publicado: (2018)

Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis
por: Ediz, Levent, et al.
Publicado: (2011)

Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis
por: Ricchiuti, Vincent, et al.
Publicado: (2022)

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
por: Shi, Jing, et al.
Publicado: (2015)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
por: Vossenaar, Erik R, et al.
Publicado: (2004)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis
por: Puszczewicz, Mariusz, et al.
Publicado: (2011)

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
por: Habets, Kim L.L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kgnp301rcvodfck955jl4u909g